<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35256767</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Murine glial progenitor cells transplantation and synthetic PreImplantation Factor (sPIF) reduces inflammation and early motor impairment in ALS mice.</ArticleTitle><Pagination><StartPage>4016</StartPage><MedlinePgn>4016</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4016</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-08064-9</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive motor neuronal disorder characterized by neuronal degeneration and currently no effective cure is available to stop or delay the disease from progression. Transplantation of murine glial-restricted precursors (mGRPs) is an attractive strategy to modulate ALS development and advancements such as the use of immune modulators could potentially extend graft survival and function. Using a well-established ALS transgenic mouse model (SOD1<sup>G93A</sup>), we tested mGRPs in combination with the immune modulators synthetic PreImplantation Factor (sPIF), Tacrolimus (Tac), and Costimulatory Blockade (CB). We report that transplantation of mGRPs into the cisterna magna did not result in increased mice survival. The addition of immunomodulatory regimes again did not increase mice lifespan but improved motor functions and sPIF was superior compared to other immune modulators. Immune modulators did not affect mGRPs engraftment significantly but reduced pro-inflammatory cytokine production. Finally, sPIF and CB reduced the number of microglial cells and prevented neuronal number loss. Given the safety profile and a neuroprotective potential of sPIF, we envision its clinical application in near future.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ambro&#x17c;kiewicz</LastName><ForeName>Karolina A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koz&#x142;owska</LastName><ForeName>Urszula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haesler</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Department of Biomedical Research, University Hospital Bern, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnea</LastName><ForeName>Eytan R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>The Society for the Investigation of Early Pregnancy (SIEP), Cherry Hill, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BioIncept LLC, Cherry Hill, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mueller</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Department of Biomedical Research, University Hospital Bern, University of Bern, Bern, Switzerland. martin.mueller@insel.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kurpisz</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. kurpimac@man.poznan.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>3K6A6FJ98O</RegistryNumber><NameOfSubstance UI="C569738">preimplantation factor, synthetic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068079" MajorTopicYN="Y">Motor Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="Y">Neuroglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="N">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="Y">Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflict of interest. M.M. received an unrestricted grant from BioIncept. E.R.B. is the founder of BioIncept and sPIF is BioIncept proprietary.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35256767</ArticleId><ArticleId IdType="pmc">PMC8901633</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-08064-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-08064-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994;331:1721&#x2013;1722. doi: 10.1056/NEJM199412223312516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199412223312516</ArticleId><ArticleId IdType="pubmed">7832899</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivan S, et al. Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp. Anim. 2015;64:147&#x2013;153. doi: 10.1538/expanim.14-0077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.14-0077</ArticleId><ArticleId IdType="pmc">PMC4427729</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruminis-Kaszkiel E, Wojtkiewicz J, Maksymowicz W. Glial-restricted precursors as potential candidates for ALS cell-replacement therapy. Acta Neurobiol. Exp. 2014;74:233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">25231843</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Savelieff MG, Sakowski SA, Feldman EL. Stem cell treatments for amyotrophic lateral sclerosis: A critical overview of early phase trials. Expert Opin. Investig. Drugs. 2019;28:525&#x2013;543. doi: 10.1080/13543784.2019.1627324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2019.1627324</ArticleId><ArticleId IdType="pmc">PMC6697143</ArticleId><ArticleId IdType="pubmed">31189354</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul Wahid SF, Law ZK, Ismail NA, Lai NM. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev. 2019;12:CD011742. doi: 10.1002/14651858.CD011742.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011742.pub3</ArticleId><ArticleId IdType="pmc">PMC6920743</ArticleId><ArticleId IdType="pubmed">31853962</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnea ER, et al. Immune regulatory and neuroprotective properties of preimplantation factor: From newborn to adult. Pharmacol. Ther. 2015;156:10&#x2013;25. doi: 10.1016/j.pharmthera.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2015.10.008</ArticleId><ArticleId IdType="pubmed">26546485</ArticleId></ArticleIdList></Reference><Reference><Citation>Moindjie H, et al. Preimplantation factor (PIF) promotes human trophoblast invasion. Biol. Reprod. 2014;91:118. doi: 10.1095/biolreprod.114.119156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.114.119156</ArticleId><ArticleId IdType="pubmed">25232018</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli M, et al. Synthetic preimplantation factor (sPIF) reduces inflammation and prevents preterm birth. PLoS ONE. 2020;15:e0232493. doi: 10.1371/journal.pone.0232493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232493</ArticleId><ArticleId IdType="pmc">PMC7279576</ArticleId><ArticleId IdType="pubmed">32511256</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss L, et al. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine. 2011;40:41&#x2013;54. doi: 10.1007/s12020-011-9438-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-011-9438-5</ArticleId><ArticleId IdType="pubmed">21424847</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar Y, et al. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model) Biol. Blood Marrow Transpl. J. Am. Soc. Blood Marrow Transpl. 2013;19:519&#x2013;528. doi: 10.1016/j.bbmt.2012.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2012.12.011</ArticleId><ArticleId IdType="pubmed">23266739</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller M, et al. PreImplantation factor promotes neuroprotection by targeting microRNA let-7. Proc. Natl. Acad. Sci. USA. 2014;111:13882&#x2013;13887. doi: 10.1073/pnas.1411674111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1411674111</ArticleId><ArticleId IdType="pmc">PMC4183321</ArticleId><ArticleId IdType="pubmed">25205808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller M, et al. PreImplantation factor bolsters neuroprotection via modulating protein kinase A and protein kinase C signaling. Cell Death Differ. 2015;22:2078&#x2013;2086. doi: 10.1038/cdd.2015.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.55</ArticleId><ArticleId IdType="pmc">PMC4816111</ArticleId><ArticleId IdType="pubmed">25976303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, et al. PreImplantation factor prevents atherosclerosis via its immunomodulatory effects without affecting serum lipids. Thromb. Haemost. 2016;115:1010&#x2013;1024. doi: 10.1160/TH15-08-0640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH15-08-0640</ArticleId><ArticleId IdType="pubmed">26842698</ArticleId></ArticleIdList></Reference><Reference><Citation>Shainer R, et al. PreImplantation factor (PIF) therapy provides comprehensive protection against radiation induced pathologies. Oncotarget. 2016 doi: 10.18632/oncotarget.10635.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.10635</ArticleId><ArticleId IdType="pmc">PMC5312289</ArticleId><ArticleId IdType="pubmed">27449294</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss L, et al. Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model. J. Neurol. Sci. 2012;312:146&#x2013;157. doi: 10.1016/j.jns.2011.07.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.07.050</ArticleId><ArticleId IdType="pubmed">21996270</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli M, et al. Preimplantation factor modulates oligodendrocytes by H19-induced demethylation of NCOR2. JCI Insight. 2021 doi: 10.1172/jci.insight.132335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.132335</ArticleId><ArticleId IdType="pmc">PMC8564895</ArticleId><ArticleId IdType="pubmed">34676826</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Liu M, Zhang W, Ming Y. Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation. Curr. Drug Metab. 2018;19:513&#x2013;522. doi: 10.2174/1389200219666180129151948.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389200219666180129151948</ArticleId><ArticleId IdType="pmc">PMC6182932</ArticleId><ArticleId IdType="pubmed">29380698</ArticleId></ArticleIdList></Reference><Reference><Citation>Saffari TM, et al. Exploring the neuroregenerative potential of tacrolimus. Expert. Rev. Clin. Pharmacol. 2019;12:1047&#x2013;1057. doi: 10.1080/17512433.2019.1675507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2019.1675507</ArticleId><ArticleId IdType="pubmed">31575290</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino J, Paster J, Benichou G. Allorecognition by T lymphocytes and allograft rejection. Front. Immunol. 2016;7:582. doi: 10.3389/fimmu.2016.00582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00582</ArticleId><ArticleId IdType="pmc">PMC5155009</ArticleId><ArticleId IdType="pubmed">28018349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenschow DJ, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992;257:789&#x2013;792. doi: 10.1126/science.1323143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1323143</ArticleId><ArticleId IdType="pubmed">1323143</ArticleId></ArticleIdList></Reference><Reference><Citation>Webber AB, Vincenti F. An update on calcineurin inhibitor-free regimens: The need persists, but the landscape has changed. Transplantation. 2016;100:836&#x2013;843. doi: 10.1097/TP.0000000000000872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000000872</ArticleId><ArticleId IdType="pubmed">27003097</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipi T, Hermanova Z, Tureckova J, Vanatko O, Anderova AM. Glial cells-the strategic targets in amyotrophic lateral sclerosis treatment. J. Clin. Med. 2020 doi: 10.3390/jcm9010261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9010261</ArticleId><ArticleId IdType="pmc">PMC7020059</ArticleId><ArticleId IdType="pubmed">31963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 2008;11:1294&#x2013;1301. doi: 10.1038/nn.2210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2210</ArticleId><ArticleId IdType="pmc">PMC2656686</ArticleId><ArticleId IdType="pubmed">18931666</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 2011;1394:90&#x2013;104. doi: 10.1016/j.brainres.2011.02.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.02.060</ArticleId><ArticleId IdType="pubmed">21354109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlowska U, et al. Assessment of immunological potential of glial restricted progenitor graft in vivo-is immunosuppression mandatory? Cells. 2021 doi: 10.3390/cells10071804.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071804</ArticleId><ArticleId IdType="pmc">PMC8308088</ArticleId><ArticleId IdType="pubmed">34359973</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e39216. doi: 10.1371/journal.pone.0039216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliara G, et al. PIF promotes brain re-myelination locally while regulating systemic inflammation clinically relevant multiple sclerosis M. smegmatis model. Oncotarget. 2017;8:21834&#x2013;21851. doi: 10.18632/oncotarget.15662.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.15662</ArticleId><ArticleId IdType="pmc">PMC5400627</ArticleId><ArticleId IdType="pubmed">28423529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandrock RW, et al. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen. Med. 2010;5:381&#x2013;394. doi: 10.2217/rme.10.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme.10.24</ArticleId><ArticleId IdType="pubmed">20455649</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak P, et al. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia. 2011;59:499&#x2013;510. doi: 10.1002/glia.21119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21119</ArticleId><ArticleId IdType="pmc">PMC3079958</ArticleId><ArticleId IdType="pubmed">21264955</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimczak A, et al. Immunological characteristics and properties of glial restricted progenitors of mice, canine primary culture suspensions, and human QSV40 immortalized cell lines for prospective therapies of neurodegenerative disorders. Cell Transpl. 2019;28:1140&#x2013;1154. doi: 10.1177/0963689719848355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689719848355</ArticleId><ArticleId IdType="pmc">PMC6767900</ArticleId><ArticleId IdType="pubmed">31124369</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeberlein A, et al. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model. Am. J. Obstet. Gynecol. 2011;205(277):e271&#x2013;276. doi: 10.1016/j.ajog.2011.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2011.06.044</ArticleId><ArticleId IdType="pubmed">22071064</ArticleId></ArticleIdList></Reference><Reference><Citation>Malysz-Cymborska I, et al. MRI-guided intrathecal transplantation of hydrogel-embedded glial progenitors in large animals. Sci. Rep. 2018;8:16490. doi: 10.1038/s41598-018-34723-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34723-x</ArticleId><ArticleId IdType="pmc">PMC6220305</ArticleId><ArticleId IdType="pubmed">30405160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, et al. Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience. 2006;139:513&#x2013;530. doi: 10.1016/j.neuroscience.2005.12.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2005.12.043</ArticleId><ArticleId IdType="pubmed">16458439</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava AK, Bulte CA, Shats I, Walczak P, Bulte JW. Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain. Exp. Neurol. 2016;275(Pt 1):154&#x2013;161. doi: 10.1016/j.expneurol.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.10.008</ArticleId><ArticleId IdType="pmc">PMC4688082</ArticleId><ArticleId IdType="pubmed">26515691</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss L, et al. Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model. J. Neurol. Sci. 2012;312:146&#x2013;157. doi: 10.1016/j.jns.2011.07.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.07.050</ArticleId><ArticleId IdType="pubmed">21996270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayrabedyan S, et al. Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice. Sci. Rep. 2019;9:12876. doi: 10.1038/s41598-019-48473-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48473-x</ArticleId><ArticleId IdType="pmc">PMC6775138</ArticleId><ArticleId IdType="pubmed">31578341</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Simone N, et al. Synthetic PreImplantation Factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response. PLoS ONE. 2017;12:e0180642. doi: 10.1371/journal.pone.0180642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180642</ArticleId><ArticleId IdType="pmc">PMC5507516</ArticleId><ArticleId IdType="pubmed">28704412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, et al. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS ONE. 2011;6:e25968. doi: 10.1371/journal.pone.0025968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025968</ArticleId><ArticleId IdType="pmc">PMC3187829</ArticleId><ArticleId IdType="pubmed">21998733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn JS, et al. Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors. Neurobiol. Dis. 2012;46:59&#x2013;68. doi: 10.1016/j.nbd.2011.12.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.044</ArticleId><ArticleId IdType="pmc">PMC3299886</ArticleId><ArticleId IdType="pubmed">22245661</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh B, et al. Split tolerance in a murine model of heterotopic en bloc chest wall transplantation. Plast. Reconstr. Surg. Glob. Open. 2017;5:e1595. doi: 10.1097/GOX.0000000000001595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000001595</ArticleId><ArticleId IdType="pmc">PMC5889449</ArticleId><ArticleId IdType="pubmed">29632774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadoyama K, Funakoshi H, Ohya W, Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci. Res. 2007;59:446&#x2013;456. doi: 10.1016/j.neures.2007.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2007.08.017</ArticleId><ArticleId IdType="pubmed">17935811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D, et al. N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nat. Neurosci. 2012;15:574&#x2013;580. doi: 10.1038/nn.3054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3054</ArticleId><ArticleId IdType="pmc">PMC3862259</ArticleId><ArticleId IdType="pubmed">22366758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellema RK, et al. Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J Neuroinflammation. 2013;10:13. doi: 10.1186/1742-2094-10-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-13</ArticleId><ArticleId IdType="pmc">PMC3614445</ArticleId><ArticleId IdType="pubmed">23347579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sizonenko SV, Kiss JZ, Inder T, Gluckman PD, Williams CE. Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain. Pediatr. Res. 2005;57:865&#x2013;872. doi: 10.1203/01.PDR.0000157673.36848.67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.PDR.0000157673.36848.67</ArticleId><ArticleId IdType="pubmed">15774844</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>